Stocks / CI
CI stock forecast
CIGNA GROUP · Healthcare · Healthcare Plans
The model's rating
Greatly Outperform
CI is rated Greatly Outperform as of September 29, 2026: its medium-term return forecast is in the top fifth of the stocks the model scores.
Create a free account to compare any two stocks; the numeric score is part of Premium.
CI is not among the 20 largest holdings published for 2026 Q3. See the portfolio
CI against the S&P 500
| Period | CI | S&P 500 (SPY) |
|---|---|---|
| 1 month | -1.0% | -0.3% |
| 3 months | -1.3% | +2.5% |
| Year to date | +0.4% | +12.7% |
| 1 year | -3.6% | +15.7% |
Total return, dividends included.
Key numbers
| Price | $275.26 |
| Market cap | 72.73 Billion |
| P/E (trailing 12 months) | 11.3 |
| P/S (trailing 12 months) | 0.3 |
| P/B (latest quarter) | 1.8 |
| Gross margin | 9.1% |
| Net profit margin | 2.3% |
| Return on equity | 15.2% |
| Beta | 0.2 |
As of July 30, 2026.
CI and its closest peers
| Stock | Company | Market cap | Model rating | |
|---|---|---|---|---|
| ELV | ELEVANCE HEALTH INC | 85.17 Billion | Outperform | ELV vs CI |
| HUM | HUMANA INC | 46.46 Billion | Greatly Outperform | CI vs HUM |
| CVS | CVS HEALTH CORP | 111.4 Billion | Outperform | CVS vs CI |
| CNC | CENTENE CORP | 30.73 Billion | Greatly Outperform | CI vs CNC |
| UNH | UNITEDHEALTH GROUP INC | 336.54 Billion | Outperform | UNH vs CI |
Questions
What does the Upfront Investment model say about CI?
The model rates CIGNA GROUP (CI) "Greatly Outperform" as of September 29, 2026, which means its medium-term return forecast is in the top fifth of the stocks the model scores. The rating is a statistical forecast, not a recommendation to buy or sell.
How is the CI rating produced?
A machine-learning model forecasts each stock's return over the coming months and ranks the forecasts against each other. The label says where this stock's forecast falls in that ranking. It is refreshed whenever the model's data updates, normally every trading day.
Is CI in the Upfront Investment model portfolio?
CI is not among the 20 largest holdings published for 2026 Q3.
The rating is the output of a statistical model and can be wrong. It is not investment advice and takes no account of your circumstances. Past performance does not guarantee future results.